Your browser doesn't support javascript.
loading
Calcium phosphate-based nanomedicine mediated CRISPR/Cas9 delivery for prostate cancer therapy.
Wei, Chao-Gang; Zhang, Rui; Wei, Lan-Yi; Pan, Peng; Zu, He; Liu, Ya-Zhen; Wang, Yong; Shen, Jun-Kang.
Affiliation
  • Wei CG; Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang R; Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Wei LY; Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Pan P; Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Zu H; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China.
  • Liu YZ; Department of Emergency, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Wang Y; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China.
  • Shen JK; Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Front Bioeng Biotechnol ; 10: 1078342, 2022.
Article in En | MEDLINE | ID: mdl-36588949

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Bioeng Biotechnol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Bioeng Biotechnol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland